Literature DB >> 17290291

Living donor kidney transplantation in a global environment.

F L Delmonico1, M A Dew.   

Abstract

Live donor kidney transplantation has become a widely sought treatment by patients with end-stage renal failure. As the outcome for the genetically and emotionally related live donor transplants is the same, this review considers live kidney transplantation from the broad scope of current international practice. Unrelated live donor transplantation can now be performed for incompatible donor recipient pairs via a simultaneous paired kidney donation. However, acceptance of the scientific data that an unrelated live donor transplant can now be performed successfully should not be misconstrued as an acceptance that an unrelated kidney may be purchased via a vendor sale. At a recent World Health Organization (WHO) conference of Middle East transplant professionals a statement of unequivocal opposition to commercialism was drafted. In the United States, the Institute of Medicine has recently published a significant report that affirms the legal prohibition of organ sales. These documents are in accord with the guiding principles of the WHO and the membership policy of The Transplantation Society. The person who gives consent to be a donor should be competent, willing to donate, free of coercion, medically and psychosocially suitable, and fully informed of the risks and benefits as a donor. With these principles established, the Amsterdam Forum has set forth a comprehensive list of medical criteria that is now used internationally in the evaluation of potential kidney donors. Guidelines of a psychosocial evaluation are also presented in this report for individuals who come forward through internet solicitation and other public appeals. It is now evident that the annual number of available deceased donors will not resolve the ongoing shortage of organs. Nevertheless, live donor kidney transplantation may not be the realistic final solution to an international public health epidemic of renal failure that is the result of an aging population of patients that have had inadequate preventive medical care.

Entities:  

Mesh:

Year:  2007        PMID: 17290291     DOI: 10.1038/sj.ki.5002125

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  16 in total

Review 1.  Paid donation: a global view.

Authors:  Nasrollah Ghahramani; S Adibul Hasan Rizvi; Benita Padilla
Journal:  Adv Chronic Kidney Dis       Date:  2012-07       Impact factor: 3.620

2.  Lupus after kidney donation to an affected male relative.

Authors:  Edward G Clark; Greg Knoll; Ann Bugeja; Kevin D Burns; R Hal Scofield
Journal:  Transplantation       Date:  2015-04       Impact factor: 4.939

Review 3.  The Benefits of a Local Kidney Exchange.

Authors:  Mohamed Saleh Ismail; Matthew Cusick; Nhu Thao Nguyen Galvan
Journal:  Tex Heart Inst J       Date:  2019-02-01

4.  [Living-donor kidney transplantation].

Authors:  A Mehrabi; H Fonouni; M Golriz; B Schmied; M Tahmasbirad; J Weitz; M W Büchler; M Zeier; J Schmidt
Journal:  Chirurg       Date:  2010-09       Impact factor: 0.955

5.  Live Donor Renal Anatomic Asymmetry and Posttransplant Renal Function.

Authors:  Bekir Tanriover; Sonalis Fernandez; Eric S Campenot; Jeffrey H Newhouse; Irina Oyfe; Prince Mohan; Burhaneddin Sandikci; Jai Radhakrishnan; Jennifer J Wexler; Maureen A Carroll; Sairah Sharif; David J Cohen; Lloyd E Ratner; Mark A Hardy
Journal:  Transplantation       Date:  2015-08       Impact factor: 4.939

Review 6.  Non-medical factors influencing access to renal transplantation.

Authors:  Eszter Panna Vamos; Marta Novak; Istvan Mucsi
Journal:  Int Urol Nephrol       Date:  2009-04-07       Impact factor: 2.370

7.  Transplant tourism in the United States: a single-center experience.

Authors:  Jagbir Gill; Bhaskara R Madhira; David Gjertson; Gerald Lipshutz; J Michael Cecka; Phuong-Thu Pham; Alan Wilkinson; Suphamai Bunnapradist; Gabriel M Danovitch
Journal:  Clin J Am Soc Nephrol       Date:  2008-10-15       Impact factor: 8.237

8.  Association of metabolic syndrome with kidney function and histology in living kidney donors.

Authors:  Y Ohashi; G Thomas; S Nurko; B Stephany; R Fatica; A Chiesa; A D Rule; T Srinivas; J D Schold; S D Navaneethan; E D Poggio
Journal:  Am J Transplant       Date:  2013-07-19       Impact factor: 8.086

9.  Risk of end-stage renal disease following live kidney donation.

Authors:  Abimereki D Muzaale; Allan B Massie; Mei-Cheng Wang; Robert A Montgomery; Maureen A McBride; Jennifer L Wainright; Dorry L Segev
Journal:  JAMA       Date:  2014-02-12       Impact factor: 56.272

10.  Pharmacological targeting of C5a receptors during organ preservation improves kidney graft survival.

Authors:  A G Lewis; G Köhl; Q Ma; P Devarajan; J Köhl
Journal:  Clin Exp Immunol       Date:  2008-05-26       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.